Results
|
10901.
|
|
|
10902.
|
|
|
10903.
|
|
|
10904.
|
|
|
10905.
|
|
|
10906.
|
|
|
10907.
|
|
|
10908.
|
|
|
10909.
|
Pyruvate therapy for Leigh syndrome due to cytochrome c oxidase deficiency. [electronic resource] by
- Komaki, Hirofumi
- Nishigaki, Yutaka
- Fuku, Noriyuki
- Hosoya, Hiroko
- Murayama, Kei
- Ohtake, Akira
- Goto, Yu-Ichi
- Wakamoto, Hiroyuki
- Koga, Yasutoshi
- Tanaka, Masashi
Producer: 20100503
In:
Biochimica et biophysica acta vol. 1800
Availability: No items available.
|
|
10910.
|
|
|
10911.
|
|
|
10912.
|
|
|
10913.
|
Global biochemical profiling identifies β-hydroxypyruvate as a potential mediator of type 2 diabetes in mice and humans. [electronic resource] by
- Zhang, Sheng
- Wang, Songyan
- Puhl, Matthew D
- Jiang, Xuntian
- Hyrc, Krzysztof L
- Laciny, Erin
- Wallendorf, Michael J
- Pappan, Kirk L
- Coyle, Joseph T
- Wice, Burton M
Producer: 20150522
In:
Diabetes vol. 64
Availability: No items available.
|
|
10914.
|
|
|
10915.
|
|
|
10916.
|
|
|
10917.
|
Ethyl pyruvate inhibits oxidation of LDL in vitro and attenuates oxLDL toxicity in EA.hy926 cells. [electronic resource] by
- Rossmann, Christine
- Nusshold, Christoph
- Paar, Margret
- Ledinski, Gerhard
- Tafeit, Erwin
- Koestenberger, Martin
- Bernhart, Eva Maria
- Sattler, Wolfgang
- Cvirn, Gerhard
- Hallström, Seth
Producer: 20180326
In:
PloS one vol. 13
Availability: No items available.
|
|
10918.
|
|
|
10919.
|
|
|
10920.
|
|